share_log

ASMPT Limited Just Missed EPS By 39%: Here's What Analysts Think Will Happen Next

ASMPT Limited Just Missed EPS By 39%: Here's What Analysts Think Will Happen Next

asmpt有限公司剛剛錯過每股收益39%:以下是分析師們認爲接下來會發生的事情
Simply Wall St ·  07/25 20:13

There's been a major selloff in ASMPT Limited (HKG:522) shares in the week since it released its second-quarter report, with the stock down 33% to HK$78.70. It looks like a pretty bad result, all things considered. Although revenues of HK$3.3b were in line with analyst predictions, statutory earnings fell badly short, missing estimates by 39% to hit HK$0.33 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

自發布第二季度報告以來,ASMPT Limited(HKG: 522)的股票在本週出現了重大拋售,該股下跌了33%,至78.70港元。考慮到所有因素,這看起來是一個非常糟糕的結果。儘管33億港元的收入與分析師的預測一致,但法定收益嚴重不足,比預期低39%,達到每股0.33港元。分析師通常會在每份收益報告中更新他們的預測,我們可以從他們的估計中判斷他們對公司的看法是否發生了變化,或者是否有任何新的問題需要注意。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

big
SEHK:522 Earnings and Revenue Growth July 26th 2024
SEHK: 522 2024 年 7 月 26 日的收益和收入增長

Taking into account the latest results, the consensus forecast from ASMPT's 20 analysts is for revenues of HK$13.7b in 2024. This reflects an okay 2.2% improvement in revenue compared to the last 12 months. Per-share earnings are expected to surge 195% to HK$2.89. Yet prior to the latest earnings, the analysts had been anticipated revenues of HK$15.2b and earnings per share (EPS) of HK$3.15 in 2024. It looks like sentiment has fallen somewhat in the aftermath of these results, with a substantial drop in revenue estimates and a minor downgrade to earnings per share numbers as well.

考慮到最新業績,ASMPT的20位分析師的共識預測是,2024年的收入爲137億港元。這反映出與過去12個月相比,收入增長了2.2%。預計每股收益將激增195%,至2.89港元。然而,在最新業績公佈之前,分析師曾預計2024年收入爲152億港元,每股收益(EPS)爲3.15港元。這些業績公佈後,市場情緒似乎有所下降,收入預期大幅下降,每股收益數字也略有下調。

The consensus price target fell 6.9% to HK$113, with the weaker earnings outlook clearly leading valuation estimates. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic ASMPT analyst has a price target of HK$150 per share, while the most pessimistic values it at HK$80.00. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

共識目標股價下跌6.9%,至113港元,盈利前景疲軟顯然領先於估值預期。但是,還有另一種思考價格目標的方法,那就是研究分析師提出的價格目標範圍,因爲範圍廣泛的估計可能表明,對業務可能的結果有不同的看法。最樂觀的ASMPT分析師將目標股價定爲每股150港元,而最悲觀的分析師則將其目標股價定爲80.00港元。注意到分析師目標股價的巨大差距了嗎?對我們來說,這意味着基礎業務存在相當廣泛的可能情景。

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's clear from the latest estimates that ASMPT's rate of growth is expected to accelerate meaningfully, with the forecast 4.4% annualised revenue growth to the end of 2024 noticeably faster than its historical growth of 0.7% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to see revenue growth of 13% annually. So it's clear that despite the acceleration in growth, ASMPT is expected to grow meaningfully slower than the industry average.

現在從大局來看,我們理解這些預測的方法之一是了解它們與過去的業績和行業增長估計相比如何。從最新估計中可以明顯看出,ASMPT的增長率預計將大幅加速,預計到2024年底的年化收入增長率爲4.4%,明顯快於過去五年0.7%的歷史增長。相比之下,同行業的其他公司預計年收入將增長13%。因此,很明顯,儘管增長加速,但預計asMPT的增長將明顯低於行業平均水平。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for ASMPT. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of ASMPT's future valuation.

最大的擔憂是,分析師下調了每股收益預期,這表明ASMPT可能會面臨業務不利因素。不幸的是,他們還下調了收入預期,我們的數據顯示,與整個行業相比,表現不佳。即便如此,每股收益對業務的內在價值更爲重要。共識目標股價大幅下降,分析師似乎沒有對最新結果感到放心,這導致對ASMPT未來估值的估計降低。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for ASMPT going out to 2026, and you can see them free on our platform here.

話雖如此,公司收益的長期軌跡比明年重要得多。我們對ASMPT的預測將持續到2026年,你可以在我們的平台上免費查看。

Plus, you should also learn about the 2 warning signs we've spotted with ASMPT .

另外,你還應該了解我們在ASMPT中發現的兩個警告信號。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件至 editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論